Status:
UNKNOWN
Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Visceral Steatosis
Hiv
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To determine the distribution of visceral fat in people living with HIV (PLHIV) with NAFLD by clinical anthropometric indicators (wais-to-hip ratio), lipid accumulation product (waist circumference an...
Detailed Description
This is single center, cross sectional study conducted at the Chronic Viral Illness Service (CVIS) of McGill University Health Center (MUHC). This is a pilot feasibility study with the aim of further ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age ≥18 years old at screening;
- Able to provide informed consent, in French or English;
- Historical HIV seropositive (ELISA with Western blot confirmation);
- Exclusion Criteria
- Contraindications to Fibroscan with CAP (pregnant women or individuals carrying a pacemaker);
- Historical evidence of co-infection with Hepatitis B or C (i.e. HBsAg or anti-HCV positive);
- Significant alcohol intake (\>21 units/week in men and \>14 units/week in women\[23\]) at screening using the Alcohol Use Disorders Identification Test (AUDIT-C) questionnaire;
- Patients with previous decompensating events from liver cirrhosis (Child-Pugh B and C), hepatocellular carcinoma, liver transplantation.
Exclusion
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05359471
Start Date
April 9 2021
End Date
June 1 2022
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Center
Montreal, Quebec, Canada